Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Anton L Pozniak"'
Autor:
Ai Kawana-Tachikawa, Josep M Llibre, Isabel Bravo, Roser Escrig, Beatriz Mothe, Jordi Puig, Maria C Puertas, Javier Martinez-Picado, Julia Blanco, Christian Manzardo, Jose M Miro, Aikichi Iwamoto, Anton L Pozniak, Jose M Gatell, Bonaventura Clotet, Christian Brander, MARAVIBOOST Investigators
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e87334 (2014)
The effect of maraviroc on the maintenance and the function of HIV-1-specific T cell responses remains unknown.Subjects recently infected with HIV-1 were randomized to receive anti-retroviral treatment with or without maraviroc intensification for 48
Externí odkaz:
https://doaj.org/article/6b50d46c8fd54efbb2340efb5487afc0
Autor:
Kim A. Papp, Jennifer Beecker, Curtis Cooper, Mark G. Kirchhof, Anton L. Pozniak, Juergen K. Rockstroh, Jan P. Dutz, Melinda J. Gooderham, Robert Gniadecki, Chih-ho Hong, Charles W. Lynde, Catherine Maari, Yves Poulin, Ronald B. Vender, Sharon L. Walmsley
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 8, Pp 1891-1892 (2023)
Externí odkaz:
https://doaj.org/article/df8a010ddfd24de28758f2c5760c3302
Autor:
Kim A. Papp, Jennifer Beecker, Curtis Cooper, Mark G. Kirchhof, Anton L. Pozniak, Juergen K. Rockstroh, Jan P. Dutz, Melinda J. Gooderham, Robert Gniadecki, Chih-ho Hong, Charles W. Lynde, Catherine Maari, Yves Poulin, Ronald B. Vender, Sharon L. Walmsley
Publikováno v:
Dermatology and Therapy, Vol 12, Iss 5, Pp 1073-1089 (2022)
Abstract Background People living with human immunodeficiency virus (PLHIV) have a similar prevalence of psoriasis as the general population, though incidence and severity correlate with HIV viral load. Adequately treating HIV early renders the infec
Externí odkaz:
https://doaj.org/article/a8e3ca70c7c04b0ea1cd9216fab2a8e2
Publikováno v:
Journal of Virus Eradication, Vol 4, Iss 2, Pp 72-79 (2018)
Background: Higher plasma tenofovir concentrations are associated with higher risks of renal and bone adverse events. The pharmacokinetic boosters ritonavir (RTV) and cobicistat (COBI) significantly increase plasma area under the curve (AUC) concentr
Externí odkaz:
https://doaj.org/article/04628aee163c4326a03c0de555455fd2
Autor:
Andrew M. Hill, Anton L. Pozniak
Publikováno v:
Journal of Virus Eradication, Vol 2, Iss 4, Pp 193-197 (2016)
Mass production of low-cost antiretrovirals (ARVs) has already allowed over 17 million individuals to access treatment for HIV infection, mainly in low-income countries. It is possible to manufacture combination ARVs for $110 per person-year, using t
Externí odkaz:
https://doaj.org/article/aa156c9bf93848ae8a3a7791f8b77b1e
Autor:
Casper Rokx, Douglas D. Richman, Michaela Müller-Trutwin, Guido Silvestri, Jan Lunzen, van, Saye Khoo, Mathias Lichterfeld, Marcus Altfeld, Carlo Federico Perno, Peter W. Hunt, Paddy Mallon, Jürgen K. Rockstroh, Anton L. Pozniak, Bonaventura Clotet, Charles A.B. Boucher
Publikováno v:
Journal of Virus Eradication, Vol 1, Iss 3, Pp 211-220 (2015)
The Second European Round Table on the Future Management of HIV took place in Barcelona, 10–11 October 2014 and focused on the HIV-1 reservoir, strategies for HIV cure and primary HIV infection (PHI). Important issues in the HIV-1 reservoir researc
Externí odkaz:
https://doaj.org/article/41c51707599d4f888dc268c048f7cc2f
Autor:
Nikolien S van De Ven, Lynne M. Mofenson, Anton L Pozniak, Andrew Hill, Jacob A Levi, Polly Clayden, Anna Garratt, Christopher Redd
Publikováno v:
Clinical Infectious Diseases. 70:2599-2606
BackgroundThe Botswana Tsepamo study reported neural tube defects (NTDs) in 4 of 426 (0.94%) infants of women receiving preconception dolutegravir (DTG) antiretroviral therapy (ART) vs 14 of 11 300 (0.12%) receiving preconception non-DTG ART. Data ar
Autor:
José M, Gatell, Lambert, Assoumou, Graeme, Moyle, Laura, Waters, Margaret, Johnson, Pere, Domingo, Julie, Fox, Esteban, Martinez, Hans-Jürgen, Stellbrink, Giovanni, Guaraldi, Mar, Masia, Mark, Gompels, Stephane, De Wit, Eric, Florence, Stefan, Esser, François, Raffi, Christoph, Stephan, Juergen, Rockstroh, Andrea, Giacomelli, Jaime, Vera, José Ignacio, Bernardino, Alan, Winston, Maria, Saumoy, Julien, Gras, Christine, Katlama, Anton L, Pozniak, Sarah, Johnston
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 68(4)
Background\ud Both immediate and deferred switching from a ritonavir-boosted protease inhibitor (PI/r)–based regimen to a dolutegravir (DTG)–based regimen may improve lipid profile.\ud \ud Methods\ud European Network for AIDS Treatment 022 Study
Autor:
Jean Cyr, Yombi, Anton L, Pozniak
Publikováno v:
AIDS reviews. 18(2)
Thanks to the emergence of combination antiretroviral therapy, HIV/AIDS has been transformed into a manageable, chronic condition in just 30 years and the life expectancy of patients living with HIV is now comparable to those without. Recent data (ST
Autor:
Kate, El Bouzidi, Ellen, White, Jean L, Mbisa, Caroline A, Sabin, Andrew N, Phillips, Nicola, Mackie, Anton L, Pozniak, Anna, Tostevin, Deenan, Pillay, David T, Dunn, Claire, Atkinson
Publikováno v:
Journal of Antimicrobial Chemotherapy
Background Darunavir is considered to have a high genetic barrier to resistance. Most darunavir-associated drug resistance mutations (DRMs) have been identified through correlation of baseline genotype with virological response in clinical trials. Ho